This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Micropharmacology Beyond Target Expression: Mapping Barriers to Intra-Tumoral Drug Delivery.
Cancer research · 2026 · first author
Imaging Mass Cytometry in Psoriatic Disease Reveals Immune Profile Heterogeneity in Skin and Synovial Tissue.
The Journal of investigative dermatology · 2025
Identification of an embryonic differentiation stage marked by Sox1 and FoxA2 co-expression using combined cell tracking and high dimensional protein imaging.
Nature communications · 2024
Latest funding
- $25,000
Genomic drivers of therapy resistant pancreatic cancer microenvironments
CIHR · 2026 · Nominated PI
- $1,273,726
Genomic drivers of therapy resistant pancreatic cancer microenvironments
CIHR · 2026 · Nominated PI
- $100,000
An integrative computational-experimental approach to map tertiary lymphoid structures in pancreatic cancer: from molecular subtypes to patient populations
CIHR · 2026 · Co-investigator
3 publications.
Micropharmacology Beyond Target Expression: Mapping Barriers to Intra-Tumoral Drug Delivery.
Jackson H
Imaging Mass Cytometry in Psoriatic Disease Reveals Immune Profile Heterogeneity in Skin and Synovial Tissue.
Eder L, Caucheteux SM, Afiuni-Zadeh S, Croitoru D, Krizova A, Limacher JJ, Ritchlin C, Jackson H, Piguet V
Identification of an embryonic differentiation stage marked by Sox1 and FoxA2 co-expression using combined cell tracking and high dimensional protein imaging.
Arekatla G, Skylaki S, Corredor Suarez D, Jackson H, Schapiro D, Engler S, Auler M, Camargo Ortega G, Hastreiter S, Reimann A, Loeffler D, Bodenmiller B, Schroeder T
Genomic drivers of therapy resistant pancreatic cancer microenvironments
Principal investigators: Jackson, Hartland W
Keywords: Biomarkers; Genomics; Imaging Mass Cytometry; In Vivo Crispr Screens; Kras Inhibitors; Multi-Modal Spatial Technologies; Pancreatic Cancer; Treatment Resistance; Tumour Microenvironment
Genomic drivers of therapy resistant pancreatic cancer microenvironments
Principal investigators: Jackson, Hartland W
Keywords: Biomarkers; Genomics; Imaging Mass Cytometry; In Vivo Crispr Screens; Kras Inhibitors; Multi-Modal Spatial Technologies; Pancreatic Cancer; Treatment Resistance; Tumour Microenvironment
An integrative computational-experimental approach to map tertiary lymphoid structures in pancreatic cancer: from molecular subtypes to patient populations
Principal investigators: Campbell, Kieran R
Keywords: Computational Approaches; Imaging; Machine Learning; Multi-Modal 'Omics; Spatial Profiling; Tertiary Lymphoid Structures
Statistical modeling of spatial omics to optimize discovery and diagnosis of key cancer drivers from patient tissue samples
Principal investigators: Wang, Shu
Keywords: Cancer; Cell-Cell Interactions; Imaging Mass Cytometry; Patient Diagnosis; Probabilistic Graphical Modeling; Single-Cell Spatial Omics; Spatial Statistics; Statistical Power; Tumor Microenvironment
High-dimensional, Single Cell Imaging Analysis to Understand the Role of Genetic Code Interpretation in Neurodevelopment and Degeneration
Principal investigators: Bu, Yong Jia
Keywords: Cell Biology; Imaging; Mass Cytometry; Myelination; Neuroscience; Protein Synthesis; Single Cell Analysis; White Matter Disorders
Robust quantification of high-dimensional cell phenotypes from human tissues
Principal investigators: Campbell, Kieran KR
Keywords: bioinformatics; cellular phenotyping; highly mutliplexed imaging; spatial biology; statistical modelling
Canada Research Chair - Tier 2
Principal investigators: Jackson, Hartland W
Keywords: Crc
Investigating the clinical relevance of spatial single cell-level epithelial heterogeneity in pancreatic ductal adenocarcinoma
Principal investigators: Nowlan, Ferris
Keywords: Bioinformatics; Imaging Mass Cytometry; Immunohistochemistry; Pancreatic Cancer; Single Cell Data; Spatial Analysis; Survival Analysis; Tumour Cells; Tumour Heterogeneity; Tumour Microenvironment
Tumour Microenvironment Immune Regulation in Hippo Signalling Dysregulated Breast Cancers
Principal investigators: Chen, Edward
Keywords: Breast Cancer Mouse Models; Cancer Biology; Cell Signalling; Crispr In Vivo Genetic Screening; Imaging Mass Cytometry; Immunology; Immunotherapy; Single-Cell Rna Sequencing; Systems Biology; Tumour Microenvironment
Quantitative Tissue Architecture
Principal investigators: Jackson, Hartland
Keywords: image cytometry; multiplexed imaging; imaging mass cytometry; single cell analysis; histology; spatial transcriptomics; tissue morphology; high-dimension immunostaining; quantitative methodology; rna/protein expression
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Lihi Eder and Vincent Piguet: 12 shared papers
- Lihi Eder and Hartland Jackson: 1 shared paper
- Vincent Piguet and Hartland Jackson: 1 shared paper
- Systems Biology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.